Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-26 · accession 0001437749-21-021221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-30 | 2021-08-27 | BLFS | Mathew Aby J. | EVP, Chief Scientific Off | S - Sale | $57.26 | -399 | 209.2K | -0.2% | -$22.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | S | D | 399 | $57.26 | 209,190 | D | — | — |